Top Story

Arterial closure, mitral valve replacement trials begin enrollment

November 19, 2017

Vivasure Medical has enrolled the first participant in an expanded indication trial of its large arteriotomy closure technology, and Medtronic has begun enrollment for a pivotal trial of its transcatheter mitral valve replacement therapy, according to company press releases.

The Frontier IV clinical study from Vivasure is a multicenter international trial of PerQseal, a fully absorbable, patch-based large-bore percutaneous closure technology.

Meeting News

MAVERIC: Transcatheter mitral valve repair system confers 6-month benefit

November 8, 2017
Transcatheter annular reduction therapy for treatment of functional mitral regurgitation was safe and effective at 6 months, according to data presented at TCT 2017…
Meeting News

New transcatheter devices show promise in severe secondary tricuspid regurgitation

November 3, 2017
Tricuspid valve therapy is a safe and feasible treatment alternative for patients with severe symptomatic tricuspid regurgitation, according to the results of two trials…
Meeting News

PREVAIL: LAA closure reduces stroke risk in nonvalvular AF

November 2, 2017
Patients with nonvalvular AF who underwent left atrial appendage closure with a self-expanding device had a decreased risk for stroke, major bleeding and mortality…
More Headlines »
The Take Home

The Take Home: TCT

Cardiology Today's Intervention, January/February 2017
The Transcatheter Cardiovascular Therapeutics Scientific Symposium was held from Oct. 29 to Nov. 2, 2016, in…
More »
Meeting News Coverage

VIDEO: David Rubenson, MD, lauds improvements in CV imaging, application

April 23, 2015
More »
Resource Centers


In the Journals

Treatment of paravalvular leak ‘a moving target’

October 6, 2017
Percutaneous intervention for paravalvular leaks is an attractive option to surgical repair, but both techniques carry…
More »